Angeles F. Estévez

Dr. Angeles F. Estévez

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Pablo Román-LópezPablo Román-López
Pablo Román-López
AEAngeles F. Estévez
Angeles F. Estévez
AMAlonso Miras
Alonso Miras
NSNuria Sanchez-Labraca
Nuria Sanchez-Labraca
FCFernando Cañadas
Fernando Cañadas
Diana María Cardona MenaDiana María Cardona Mena
Diana María Cardona Mena
It has recently been found that microbes in the gut may regulate brain processes through the gut microbiota–brain axis, which modulates affection, motivation and higher cognitive functions. According to this finding, the use of probiotics may be a potential treatment to improve physical, psychological and cognitive status in clinical populations with altered microbiota balance such as those with fibromyalgia (FMS). Thus, the aim of the present pilot study with a double-blind, placebo-controlled, randomised design was to test whether a multispecies probiotic may improve cognition, emotional symptoms and functional state in a sample of patients diagnosed with FMS. Pain, impact of FMS, quality of life, anxiety and depressive symptoms were measured during the pre- and post-intervention phases; participants also completed two computerised cognitive tasks to assess impulsive choice and decision-making. Finally, urinary cortisol concentration was determined. To our knowledge, this is the first study that explore the effect of a multispecies probiotic in FMS patients. Our results indicated that probiotics improved impulsivity and decision-making in these patients. However, more research is needed to further explore the potential effects of probiotics on other cognitive functions affected in FMS as well as in other clinical populations.

1 August 2012 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
MMMargarita Moreno
Margarita Moreno
AEAngeles F. Estévez
Angeles F. Estévez
FZFLOR ZALDÍVAR
FLOR ZALDÍVAR
JMJose Manuel García Montes
Jose Manuel García Montes
VGValeria E. Gutiérrez-Ferre
Valeria E. Gutiérrez-Ferre
PFPilar Flores
Pilar Flores

1 February 2001 in Learning and Motivation
Verified
Journal Article
Closed access
AEAngeles F. Estévez
Angeles F. Estévez
LFLuis J Fuentes
Luis J Fuentes
PMPaloma Marı́-Beffa
Paloma Marı́-Beffa
CGCarmen González
Carmen González
DADolores Alvarez
Dolores Alvarez

1 April 2001 in Personality and Individual Differences
Verified
Journal Article
Closed access
CGCarmen González
Carmen González
LFLuis J Fuentes
Luis J Fuentes
JCJose A Carranza
Jose A Carranza
AEAngeles F. Estévez
Angeles F. Estévez

15 June 2018 in Beneficial Microbes
Verified
Journal Article
Closed access
Pablo Román-LópezPablo Román-López
Pablo Román-López
FCF. Carrillo-Trabalón
F. Carrillo-Trabalón
NSNuria Sanchez-Labraca
Nuria Sanchez-Labraca
FCF. Cañadas
F. Cañadas
AEAngeles F. Estévez
Angeles F. Estévez
Diana María Cardona MenaDiana María Cardona Mena
Diana María Cardona Mena
Evidence suggests that the gut microbiota might play an important role in fibromyalgia syndrome (FMS) and chronic fatigue syndrome (CFS). Our goal is to systematically review the reported effect of probiotic treatments in patients diagnosed with FMS or CFS. A systematic review was carried out using 14 databases (PubMed, Cochrane Library, Scopus, PsycINFO, and others) in February 2016 to search for randomised controlled trials (RCTs) and pilot studies of CFS or FMS patient, published in the last ten years (from 2006 to 2016). The Jadad scale was used to asseverate the quality of the clinical trials considered. Two studies (n=83) met the inclusion criteria, which were performed in CFS patients and both studies were considered as a ‘High range of quality score’. The administration of Lactobacillus casei strain Shirota in CFS patients, over the course of 8 weeks, reduced anxiety scores. Likewise, this probiotic changed the faecal composition following 8 weeks of treatment. Additionally, the treatment with Bifidobacterium infantis 35624 in CFS patients, during the same period, reduced inflammatory biomarkers. The evidence about the usefulness of probiotics in CFS and FMS patients remains limited. The studied strains of probiotics have demonstrated a significant effect on modulating the anxiety and inflammatory processes in CFS patients. However, more experimental research, focusing mainly on the symptoms of the pathologies studied, is needed.

1 January 2003 in American Journal on Mental Retardation
Verified
Journal Article
Closed access
AEAngeles F. Estévez
Angeles F. Estévez
LFLuis J Fuentes
Luis J Fuentes
JOJ. Bruce Overmier
J. Bruce Overmier
CGCarmen González
Carmen González
In previous studies, researchers have demonstrated that learning of symbolic relations is facilitated when a particular outcome is associated with each relation to be learned. In the present study, we extend this differential outcomes procedure to children and adults with Down syndrome who had to learn a symbolic conditional discrimination task. Participants showed a better terminal accuracy and a faster learning of the task when the alternative correct responses were each followed by unique different outcomes than when nondifferential outcomes were arranged. These findings confirm that the differential outcomes procedure can be a useful tool to ameliorate discriminative learning deficits and demonstrate the benefits of this procedure for people with Down syndrome. Editor-in-charge: William E. MacLean, Jr